TriSalus Life Sciences's top three insider shareholders as of May 14, 2026 are Acquisition Sponsor Llc Medtech (TenPercentOwner, 6.25Mn shares), James Emmett Young (Chief Financial Officer, 49.66K shares), Mats Wahlstrom (Director, 40.91K shares).
| Holder | Position | Shares (Direct) | Shares (Indirect) | Report Date |
|---|---|---|---|---|
| Acquisition Sponsor Llc Medtech | - | 6,249,999 | 0 | 27 Jun, 2023 |
| Acquisition Sponsor Llc Medtech | - | 6,249,999 | 0 | 27 Jun, 2023 |
| Equity Ab Frankenius | - | 6,230,748 | 0 | 19 Dec, 2024 |
| Michael P Stansky | - | 787,132 | 199,698 | 23 Feb, 2026 |
| David J Matlin | - | 941,944 | 0 | 06 Jan, 2025 |
| Mary T Szela | Ceo And President | 752,987 | 0 | 20 Mar, 2026 |
| David Patience | Chief Financial Officer | 268,657 | 0 | 23 Feb, 2026 |
| George Kelly Martin | - | 0 | 247,176 | 10 Sep, 2024 |
| Arjun Jj Desai | - | 247,127 | 0 | 12 Dec, 2024 |
| Sean Murphy | Chief Manuf, Strategybus Dev. | 0 | 197,732 | 29 Jan, 2025 |
| Bryan F. Cox | Chief Of Research | 163,415 | 0 | 20 Mar, 2026 |
| Jennifer Stevens | Chief Regulatory Officer | 124,110 | 0 | 20 Mar, 2026 |
| Sean Murphy | Chief Manuf, Strategybus Dev. | 123,989 | 0 | 21 May, 2025 |
| Richard Marshak | Chief Commercial Officer | 110,397 | 0 | 20 Mar, 2026 |
| Jodi Devlin | Chief Of Clinical Operations | 97,364 | 0 | 20 Mar, 2026 |
| Steven C Katz | Chief Medical Officer | 68,587 | 0 | 14 Feb, 2024 |
| James Emmett Young | Chief Financial Officer | 49,663 | 0 | 21 May, 2025 |
| James Emmett Young | Chief Financial Officer | 49,663 | 0 | 21 May, 2025 |
| Mats Wahlstrom | - | 40,915 | 0 | 19 Dec, 2024 |
| Mats Wahlstrom | - | 40,915 | 0 | 19 Dec, 2024 |
| William Valle | - | 30,487 | 0 | 23 Feb, 2026 |
| William Valle | - | 30,487 | 0 | 23 Feb, 2026 |
| James Emmett Young | Chief Financial Officer | 0 | 30,000 | 06 Feb, 2025 |
| James Emmett Young | Chief Financial Officer | 0 | 30,000 | 06 Feb, 2025 |
| Financial Llc Magnetar | - | 0 | 16,668 | 14 Jun, 2023 |
| Liselotte Hyveled | - | 10,040 | 0 | 06 Jan, 2025 |
| Gary B. Gordon | - | 9,756 | 0 | 23 Feb, 2026 |
* Please note that the shares above only reflect shares from the fund portfolio and the institutional portfolio. Shares from the personal portfolio are excluded from this Institutional Ownership Page. See these insiders' latest transactions here on Insider Page.
| Transaction Date | Insider Name | Security Class | Transaction Type | Shares Traded | Price | Shares Remaining | Ownership | Code |
|---|---|---|---|---|---|---|---|---|
| 11 Mar, 2026 | Bryan F. Cox | Common Stock | D | 1,138 | $4.13 | 165,461 | D | S |
| 11 Mar, 2026 | Jennifer Stevens | Common Stock | D | 1,204 | $4.13 | 126,436 | D | S |
| 11 Mar, 2026 | Richard Marshak | Common Stock | D | 1,449 | $4.13 | 112,405 | D | S |
| 11 Mar, 2026 | Mary T Szela | Common Stock | D | 4,358 | $4.13 | 768,931 | D | S |
| 11 Mar, 2026 | Jodi Devlin | Common Stock | D | 1,162 | $4.13 | 99,409 | D | S |
| 12 Mar, 2026 | Richard Marshak | Common Stock | D | 1,589 | $4.09 | 110,816 | D | S |
| 12 Mar, 2026 | Jodi Devlin | Common Stock | D | 1,772 | $4.09 | 97,637 | D | S |
| 12 Mar, 2026 | Bryan F. Cox | Common Stock | D | 1,467 | $4.09 | 163,994 | D | S |
| 17 Mar, 2026 | Mary T Szela | Common Stock | D | 15,944 | $3.85 | 752,987 | D | S |
| 12 Mar, 2026 | Jennifer Stevens | Common Stock | D | 1,552 | $4.09 | 124,884 | D | S |
| 16 Mar, 2026 | Bryan F. Cox | Common Stock | D | 579 | $4.12 | 163,415 | D | S |
| 16 Mar, 2026 | Richard Marshak | Common Stock | D | 419 | $4.12 | 110,397 | D | S |
| 16 Mar, 2026 | Jodi Devlin | Common Stock | D | 273 | $4.12 | 97,364 | D | S |
| 16 Mar, 2026 | Jennifer Stevens | Common Stock | D | 774 | $4.12 | 124,110 | D | S |
| 23 Feb, 2026 | Mary T Szela | Common Stock | A | 30,487 | $4.10 | 773,289 | D | P |
| 23 Feb, 2026 | William Valle | Common Stock | A | 30,487 | $4.10 | 30,487 | D | P |
| 23 Feb, 2026 | Gary B. Gordon | Common Stock | A | 9,756 | $4.10 | 9,756 | D | P |
| 23 Feb, 2026 | Michael P Stansky | Common Stock | A | 243,900 | $4.10 | 787,132 | D | P |
| 23 Feb, 2026 | David Patience | Common Stock | A | 3,657 | $4.10 | 268,657 | D | P |
| 23 Feb, 2026 | William Valle | Common Stock | A | 30,487 | $4.10 | 30,487 | D | P |